ProShare Advisors’s Nuvation Bio NUVB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $99.8K | Buy |
51,176
+11,928
| +30% | +$23.3K | ﹤0.01% | 1878 |
|
2025
Q1 | $69.1K | Sell |
39,248
-11,812
| -23% | -$20.8K | ﹤0.01% | 1906 |
|
2024
Q4 | $136K | Buy |
51,060
+16,801
| +49% | +$44.7K | ﹤0.01% | 2000 |
|
2024
Q3 | $78.5K | Buy |
34,259
+14,746
| +76% | +$33.8K | ﹤0.01% | 1919 |
|
2024
Q2 | $57K | Sell |
19,513
-6,660
| -25% | -$19.4K | ﹤0.01% | 1733 |
|
2024
Q1 | $95.3K | Buy |
26,173
+2,062
| +9% | +$7.51K | ﹤0.01% | 1831 |
|
2023
Q4 | $36.4K | Buy |
24,111
+5,186
| +27% | +$7.83K | ﹤0.01% | 1888 |
|
2023
Q3 | $25.4K | Sell |
18,925
-21
| -0.1% | -$28 | ﹤0.01% | 1770 |
|
2023
Q2 | $34.1K | Buy |
18,946
+5,246
| +38% | +$9.44K | ﹤0.01% | 1808 |
|
2023
Q1 | $22.7K | Sell |
13,700
-1,277
| -9% | -$2.12K | ﹤0.01% | 1725 |
|
2022
Q4 | $28.8K | Buy |
14,977
+2,147
| +17% | +$4.12K | ﹤0.01% | 1787 |
|
2022
Q3 | $30K | Sell |
12,830
-245
| -2% | -$573 | ﹤0.01% | 1700 |
|
2022
Q2 | $43K | Sell |
13,075
-16,732
| -56% | -$55K | ﹤0.01% | 1722 |
|
2022
Q1 | $157K | Sell |
29,807
-4,924
| -14% | -$25.9K | ﹤0.01% | 1945 |
|
2021
Q4 | $295K | Buy |
+34,731
| New | +$295K | ﹤0.01% | 1801 |
|